Prostate Cancer Archives - Page 235 of 237 - Renal and Urology News

Prostate Cancer

Screening Cuts Risk of Advanced PCa

Biennial PSA screening decreases the likelihood of being diagnosed with metastatic prostate cancer, but nearly doubles the chance of being diagnosed with prostate cancer of any type, a Swedish sudy found.

Oral Platinum Analogue Looks Good

NEW YORK—Satraplatin, the first oral platinum analogue, is among the more promising second-line treatments for hormone-refractory prostate cancer (HRPC), a researcher said here at the 2006 Chemotherapy Foundation Symposium.

Drug Is Beneficial In Some PCa Cases

NEW YORK CITY—Results of the largest clinical trial ever conducted in non-metastatic prostate cancer suggest that bicalutamide (Casodex) added to standard care may improve overall survival in men with locally advanced disease undergoing radiotherapy.

New Medication Improves PCa Outcomes

NEW YORK—A high-dose oral formulation of calcitriol, called DN 101 and used in combination with docetaxel, is associated with longer survival in men with hormone-refractory prostate cancer (HRPC), according to a recent study.

Next post in News